Variables Associated With Heart Failure Compared for Men and Women
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 28, 2025 -- Asthma, depression, anxiety, and hypothyroidism are associated with heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) among women, according to a study published online Aug. 22 in the Journal of Primary Care and Community Health.
Kristen Yeh, from the Cooper Medical School of Rowan University in Camden, New Jersey, and colleagues examined the risk factors associated with heart failure in women versus men in a retrospective medical record review. Variables were compared in men and women with HFpEF and HFrEF.
The study included 460 women and 258 men with HFpEF. The researchers found that women with HFpEF had higher prevalence rates of older age, asthma, osteoarthritis, depression, hypothyroidism, and anxiety compared with men with HFpEF. In women, the odds of HFpEF were greater with increasing age per year, increasing body mass index (BMI), rheumatological disorder, mental health disorder such as depression or anxiety, asthma, and hypothyroidism (odds ratios, 1.043, 1.037, 1.920, 1.898, 1.807, and 1.973, respectively). Data were included for 225 women and 250 men with HFrEF. Compared with men with HFrEF, women with HFrEF had higher prevalence rates of asthma, depression, hypothyroidism, and anxiety. For Black race, the odds of HFrEF were greater in women (odds ratio, 1.455).
"Women with HFpEF had higher prevalence of old age, elevated BMI, asthma, osteoarthritis, depression, anxiety, and hypothyroidism; while women with HFrEF had higher prevalence of Black race, asthma, depression, anxiety, and hypothyroidism," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis
THURSDAY, Aug. 28, 2025 -- Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart failure among patients receiving...
Cancer Survivors More Likely to Take Rx for Mental Health Conditions
THURSDAY, Aug. 28, 2025 -- U.S. cancer survivors are significantly more likely to take medications for depression and anxiety compared with noncancer survivors, according to a...
COVID-19 Tied to Higher Risk for Inflammatory Diseases of the Airways
THURSDAY, Aug. 28, 2025 -- People who have had COVID-19 have an increased risk for developing certain new-onset type 2 inflammatory diseases of the airways, while receipt of a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.